🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter study will enroll approximately 185 participants with meta...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-07
Trial ID
NCT00668148
This randomized phase II trial studies cisplatin and etoposide to see how w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2009-07-16
Trial ID
NCT00887159
Treatments Being Tested
This randomized phase II trial is studying bicalutamide, goserelin, or leup...
Status
Completed
Location
Fairbanks Memorial Hospital
Start Date
2010-12
Trial ID
NCT01120236
This phase I trial studies the side effects and best dose of cixutumumab wh...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01204476
Treatments Being Tested
The purpose of this study is to determine whether IMC-A12 or IMC-1121B (ram...
Status
Completed
Location
ImClone Investigational Site
Start Date
2008-08
Trial ID
NCT00683475
Treatments Being Tested
This phase II trial studies how well giving cixutumumab works in treating p...
Status
Completed
Location
Thomas Jefferson University Hospital
Start Date
2011-08
Trial ID
NCT01413191
Treatments Being Tested
Determine the 6-month progression free survival (PFS) rate associated with ...
Status
Completed
Location
ImClone Investigational Site
Start Date
2009-02
Trial ID
NCT00781911
Treatments Being Tested
This randomized phase I/II trial is studying the side effects and best dose...
Status
Completed
Location
NEA Baptist Memorial Hospital
Start Date
2008-03
Trial ID
NCT00617708
Treatments Being Tested
This randomized phase I/II trial is studying the side effects and best dose...
Status
Completed
Location
University of Colorado
Start Date
2008-10
Trial ID
NCT00778167
Treatments Being Tested
The goal of this clinical research study is to give cetuximab and/or IMC-A1...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-10-17
Trial ID
NCT00957853
Treatments Being Tested